MedTrace Logo

Intervention to Improve the Adherence in Community Pharmacies

NCT04195191 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2020-02-05

No results posted yet for this study

Summary

The ANM is the first initiative that puts advanced pharmaceutical care into practice in Andalusia (Spain). The aim of this is study is to evaluate the effectiveness of the intervention Assistance to New Medicines (ANM) in the improvement of adherence to treatment in community pharmacies.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD
  • Arterial Hypertension
  • Diabetes Mellitus

Interventions

OTHER

ANM

communication intervention

OTHER

Placebo

regular assistance in community pharmacies

Sponsors & Collaborators

  • Andalusian School of Public Health

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2020-03-02
Completion
2020-07-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04195191 on ClinicalTrials.gov